Hans-Joachim Kabitz

Hans-Joachim Kabitz

Auto-generated profile, based on publicly available information

Hans-Joachim Kabitz

Department of Pneumology, Cardiology and Intensive Care Medicine, Klinikum Konstanz, Konstanz, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
PLPierantonio Laveneziana
Pierantonio Laveneziana
AAAndre Albuquerque
Andre Albuquerque
AAAndrea Aliverti
Andrea Aliverti
TBTony Babb
Tony Babb
EBEsther Barreiro
Esther Barreiro
SVSamuel Verges
Samuel Verges
Assessing respiratory mechanics and muscle function is critical for both clinical practice and research purposes. Several methodological developments over the past two decades have enhanced our understanding of respiratory muscle function and responses to interventions across the spectrum of health and disease. They are especially useful in diagnosing, phenotyping and assessing treatment efficacy in patients with respiratory symptoms and neuromuscular diseases. Considerable research has been undertaken over the past 17 years, since the publication of the previous American Thoracic Society (ATS)/European Respiratory Society (ERS) statement on respiratory muscle testing in 2002. Key advances have been made in the field of mechanics of breathing, respiratory muscle neurophysiology (electromyography, electroencephalography and transcranial magnetic stimulation) and on respiratory muscle imaging (ultrasound, optoelectronic plethysmography and structured light plethysmography). Accordingly, this ERS task force reviewed the field of respiratory muscle testing in health and disease, with particular reference to data obtained since the previous ATS/ERS statement. It summarises the most recent scientific and methodological developments regarding respiratory mechanics and respiratory muscle assessment by addressing the validity, precision, reproducibility, prognostic value and responsiveness to interventions of various methods. A particular emphasis is placed on assessment during exercise, which is a useful condition to stress the respiratory system.

1 December 2007 in Chest
Verified
Journal Article
Closed access
PDF file
JSJan H. Storre
Jan H. Storre
BSBoris Steurer
Boris Steurer
HKHans-Joachim Kabitz
Hans-Joachim Kabitz
MDMichael Dreher
Michael Dreher
WWWolfram Windisch
Wolfram Windisch

6 March 2015 in Pneumologie
Verified
Journal Article
Closed access
CCC.-P. Criée
C.-P. Criée
XBX. Baur
X. Baur
DBD. Berdel
D. Berdel
DBD. Bösch
D. Bösch
MGM. Gappa
M. Gappa
HWH. Worth
H. Worth
Die Spirometrie ist eine einfache Lungenfunktionsuntersuchung zur Diagnostik obstruktiver Ventilationsstörungen und zur Bestimmung von Lungenvolumina. Eine obstruktive Ventilationsstörung ist durch eine Verminderung des Tiffeneau-Index (FEV1/FVC) auf Werte unterhalb des 5. Perzentils (entsprechend dem unteren Grenzwert, lower limit of normal LLN) definiert. Eine verminderte Vitalkapazität (FVC) kann Ausdruck einer restriktiven Ventilationsstörung sein, die durch eine Verminderung der Totalen Lungenkapazität (TLC) auf Werte unterhalb des 5. Perzentils (LLN) definiert ist. Zur Differenzialdiagnose einer Lungenüberblähung ist daher eine bodyplethysmografische Messung der TLC notwendig. Neue spirometrische Referenzwerte, erhoben an mehr als 74 000 gesunden Probanden im Alter von 3 bis 95 Jahren, wurden 2012 publiziert (GLI 2012). Sie sollten zur Bestimmung von LLN und zur Abschätzung des Schweregrades von Ventilationsstörungen verwendet werden. Die Leitlinie beschreibt die Standardisierung der Spirometrie und ihre Befundinterpretation unter Berücksichtigung der neuen Referenzwerte. Spirometry is a simple test and considered the gold standard in lung function. An obstructive ventilatory defect is a disproportionate reduction of maximal airflow from the lung in relation to the maximal volume that can be displaced from the lung. It implies airway narrowing and is defined by a reduced FEV1/FVC ratio below the 5th percentile of the predicted value (lower limit of normal, LLN). A restrictive disorder may be suspected when vital capacity (FVC) is reduced and FEV1/FVC is normal. It is definitely proven, however, only by a decrease in TLC below the 5th percentile of predicted value (LLN). The measurement of TLC by body plethysmography is necessary to confirm or exclude a restrictive defect or hyperinflation of the lung when FVC is below the LLN. 2012 a task force of the ERS published new reference values based on 74 187 records from healthy non-smoking males and females from 26 countries. The new reference equations for the 3–95 age range are now available that include appropriate age-dependent mean values and lower limits of normal (LLN). This presentation aims at providing the reader with recommendations dealing with standardization and interpretation of spirometry.

11 December 2007 in Clinical Science
Verified
Journal Article
Closed access
PDF file
HKHans-Joachim Kabitz
Hans-Joachim Kabitz
ASAnja Schwoerer
Anja Schwoerer
HBHinrich-Cordt Bremer
Hinrich-Cordt Bremer
FSFlorian Sonntag
Florian Sonntag
SWStephan Walterspacher
Stephan Walterspacher
WWWolfram Windisch
Wolfram Windisch
It has been suggested that impaired respiratory muscle function occurs in patients with PH (pulmonary hypertension); however, comprehensive investigations of respiratory muscle function, including the application of non-volitional tests, needed to verify impairment of respiratory muscle strength in patients with PH have not yet been performed. In the present study, respiratory muscle function was assessed in 31 patients with PH (20 females and 11 males; mean pulmonary artery pressure, 51±20 mmHg; median World Health Organization class 3.0±0.5; 25 patients with pulmonary arterial hypertension and six patients with chronic thromboembolic PH) and in 31 control subjects (20 females and 11 males) well-matched for gender, age and BMI (body mass index). A 6-min walking test was performed to determine exercise capacity. Volitionally assessed maximal inspiratory (7.5±2.1 compared with 6.2±2.8 kPa; P=0.04) and expiratory (13.3±4.2 compared with 9.9±3.4 kPa; P<0.001) mouth pressures, sniff nasal (8.3±1.9 compared with 6.6±2.2 kPa; P=0.002) and transdiaphragmatic (11.3±2.5 compared with 8.7±2.5 kPa; P<0.001) pressures, non-volitionally assessed twitch mouth (1.46±0.43 compared with 0.97±0.41 kPa; P<0.001) and transdiaphragmatic (2.08±0.55 compared with 1.47±0.72 kPa; P=0.001) pressures during bilateral anterior magnetic phrenic nerve stimulation were markedly lower in patients with PH compared with control subjects. Maximal inspiratory mouth (r=0.58, P<0.001) and sniff transdiaphragmatic (r=0.43, P=0.02) pressures were correlated with the 6-min walking distance in patients with PH. In conclusion, the present study provides strong evidence that respiratory muscle strength is reduced in patients with PH compared with well-matched control subjects. Furthermore, the 6-min walking distance is significantly linked to parameters assessing inspiratory muscle strength.

1 December 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
MHMarius Hoeper
Marius Hoeper
CAChristian Apitz
Christian Apitz
EGEkkehard Grünig
Ekkehard Grünig
MHMichael Halank
Michael Halank
RERalf Ewert
Ralf Ewert
HGHossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani

20 December 2012 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
SWStephan Walterspacher
Stephan Walterspacher
DSDaniel Schlager
Daniel Schlager
DWDavid J. Walker
David J. Walker
JMJoachim Müller-Quernheim
Joachim Müller-Quernheim
WWWolfram Windisch
Wolfram Windisch
HKHans-Joachim Kabitz
Hans-Joachim Kabitz
Interstitial lung diseases limit daily activities, impair quality of life and result in (exertional) dyspnoea. This has mainly been attributed to a decline in lung function and impaired gas exchange. However, the contribution of respiratory muscle dysfunction to these limitations remains to be conclusively investigated.Interstitial lung disease patients and matched controls performed body plethysmography, a standardised 6-min walk test, volitional tests (respiratory drive (P0.1), global maximal inspiratory mouth occlusion pressure (PImax), sniff nasal pressure (SnPna) and inspiratory muscle load) and nonvolitional tests on respiratory muscle function and strength (twitch mouth and transdiaphragmatic pressure during bilateral magnetic phrenic nerve stimulation (TwPmoand TwPdi)).25 patients and 24 controls were included in the study.PImaxand SnPnaremained unaltered (both p>0.05), whereasP0.1and the load on the inspiratory muscles were higher (both p<0.05) in interstitial lung disease patients compared with controls. TwPmoand TwPdiwere lower in interstitial lung disease patients (mean±sdTwPmo0.86±0.4versus1.32±0.4, p<0.001; TwPdi1.34±0.6versus1.88±0.5, p=0.022).Diaphragmatic force generation seems to be impaired in this cohort of interstitial lung disease patients while global respiratory muscle strength remains preserved. Central respiratory drive and the load imposed on the inspiratory muscles are increased. Whether impaired respiratory muscle function impacts morbidity and mortality in interstitial lung disease patients needs to be investigated in future studies.